— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected.
— Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue.
— Sales from Eurasia Banking dropped by 13% and that from the Americas Banking declined by 3%. Total retail sales fell by 18%.
— Looking ahead into the full year 2020, the company expects its total revenue in the range of $4.2-4.3 billion. The consensus estimates revenue of $4.27 billion.
— Adjusted EBITDA is expected to be in the range of $430-470 million and net cash provided by operating activities is predicted to be in the $170-200 million range for the full year.
— Capital expenditures are anticipated to be about $70 million while free cash flow is projected to be $100-130 million for the full year 2020.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
